₹0.99
(Market cap
₹6 Cr
Revenue (TTM)
₹17 Cr
P/E Ratio
6.7
P/B Ratio
1.4
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
₹1 Cr
-
ROE
-41.3 %
-
ROCE
-42.6 %
-
Industry P/E
35.22
-
EV/EBITDA
46.9
-
Debt to Equity
0
-
Book Value
₹14.5
-
EPS
₹3.1
-
Face value
10
-
Shares outstanding
3,000,300
10 Years Aggregate
CFO
₹0.57 Cr
EBITDA
₹0.39 Cr
Net Profit
₹-0.50 Cr
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Brawn Biotech
| -2.6 | -3.1 | 9.3 | 23.0 | 11.8 | 0.0 | -4.4 |
|
BSE Healthcare
| 10.2 | 1.2 | 12.0 | 10.9 | 24.0 | 14.1 | 12.4 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Brawn Biotech
| -3.8 | -2.7 | 11.2 | -13.8 | -9.3 | -8.1 | -34.2 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Brawn Biotech
|
20.9 | 6.3 | 17.0 | 0.9 | -2.6 | 23.4 | 6.7 | 1.4 |
| 3,065.2 | 38,263.4 | 5,452.9 | 1,056.0 | 22.4 | 25.4 | 36.2 | 8.5 | |
| 8,433.5 | 21,016.5 | 2,275.6 | 187.5 | 10.3 | 22.9 | 112.1 | 24.1 | |
| 2,503.5 | 19,049.7 | 2,187.2 | 649.7 | 31.5 | 19 | 29.7 | 5.3 | |
| 1,868.6 | 11,397.2 | 1,403.2 | 185.1 | -- | 27.4 | 61.6 | 15.3 | |
| 1,448.4 | 20,037.5 | 3,129.4 | 647.4 | 26.9 | 18.1 | 32.3 | 5.1 | |
| 2,193.5 | 35,151.1 | 4,147.8 | 709.5 | 22.3 | 19.1 | 49.5 | 8.5 | |
| 4,533.7 | 20,725.6 | 2,519.7 | 722.4 | 33.6 | 18.8 | 28.7 | 4.9 | |
| 6,244.0 | 10,410.0 | 1,408.0 | 326.9 | 30.8 | 57.1 | 31.8 | 19.8 | |
| 551.4 | 10,770.7 | 1,538.1 | 226.2 | 20.4 | 9 | 44.3 | 4.2 |
Shareholding Pattern
View DetailsNews & Analysis
All NewsNo Review & Analysis are available.
About Brawn Biotech
Brawn Biotech Limited engages in the wholesale of pharmaceutical and medical goods in India and internationally. It offers various pharmaceutical formulations, including antibacterial, cardiovascular, antidiabetic, analgesic, gastrointestinal,... antifungal, skin care, antipsychotic, antiasthmatic, antacid, antimalarial, and nutritional products. The company was formerly known as Brawn Pharmaceuticals Limited and changed its name to Brawn Biotech Limited in November 2010. Brawn Biotech Limited was founded in 1985 and is based in Gurugram, India. Read more
-
Incorporated
1985
-
Chairman
--
-
Managing Director
--
-
Headquarters
New Delhi, Delhi
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
FAQs for Brawn Biotech
What is the current share price of Brawn Biotech Ltd Today?
The share price of Brawn Biotech Ltd is ₹20.94 (BSE) as of 19-Jun-2026 IST. Brawn Biotech Ltd has given a return of 11.76% in the last 3 years.
What is the current PB & PE ratio of Brawn Biotech Ltd?
The P/E ratio of Brawn Biotech Ltd is 6.68 times as on 19-Jun-2026, a 81 discount to its peers’ median range of 35.22 times.
The P/B ratio of Brawn Biotech Ltd is 1.45 times as on 19-Jun-2026, a 71 discount to its peers’ median range of 4.93 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
0.00
|
1.45
|
|
2024
|
0.00
|
1.18
|
|
2023
|
0.00
|
0.79
|
|
2022
|
0.00
|
0.72
|
|
2021
|
0.00
|
0.75
|
What is the 52 Week High and Low of Brawn Biotech Ltd?
The 52-week high and low of Brawn Biotech Ltd are Rs 24.37 and Rs 16.16 as of 22-Jun-2026.
What is the market cap of Brawn Biotech Ltd?
Brawn Biotech Ltd has a market capitalisation of ₹ 6 Cr as on 19-Jun-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in Brawn Biotech Ltd?
Before investing in Brawn Biotech Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.